Awareness and knowledge of HPV, cervical cancer, and vaccines in young women after first delivery in São Paulo, Brazil - a cross-sectional study

BMC Women's Health

Volumn 10, Issue , 2010, Pages

  Rama, Cristina H ^a   Villa, Luisa L ^b   Pagliusi, Sonia ^c   Andreoli, Maria A ^b   Costa, Maria C ^b   Aoki, Aline L ^d   Longatto Filho, Adhemar ^e,f   Eluf Neto, José ^e  

^a HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS   (Brazil)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF SANTO AMARO   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; BRAZIL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PAPILLOMAVIRUS INFECTION; PATIENT EDUCATION; PRIMIPARA; QUESTIONNAIRE; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; AGE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; PARITY; PSYCHOLOGICAL ASPECT; UTERINE CERVIX TUMOR;

ADOLESCENT; ADULT; AGE FACTORS; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MULTIVARIATE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARITY; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 78650328405     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-10-35     Document Type: Article

References (25)

1. Walboomers JMM, Jacobs MV, Manos MM, Bosh FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431≥3.0.CO;2-F, 10451482.
2. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-27.
3. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27. 10.1016/j.virol.2004.03.033, 15183049.
4. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, . Centers for Disease Control and Prevention Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-2):1-24. Centers for Disease Control and Prevention.
5. Pollack AE, Balkin M, Edouard L, Cutts F, Broutet N, . WHO/UNFPA Working Group on Sexual and Reproductive Health and HPV Vaccines Ensuring access to HPV vaccines through integrated services: a reproductive health perspective. Bull World Health Organ 2007, 85:57-63. 2636212, 17242759, WHO/UNFPA Working Group on Sexual and Reproductive Health and HPV Vaccines.
6. Rama CH, Villa LL, Pagliusi S, Andreoli MA, Costa MC, Thomann P, Alves VAF, Longatto-Filho A, Eluf-Neto J. Opportunity for catch-up HPV vaccination in young women after first delivery. J Epidemiol Community Health 2010, 64:610-5. 10.1136/jech.2008.086439, 19692713.
7. McCullagh P, Nelder JA. Generalized linear models. 1989, New York: Chapman and Hall, 2.
8. Breslow NE, Day NE. Statistical methods in cancer research. The analysis of case-control studies. Publ. no. 32 1980, I(32). Lyon: International Agency for Research on Cancer.
9. StataCorp 2003, Stata Statistical Software: Release 8.2 College Station, TX, Stata Corporation, StataCorp.
10. USA FDA (2006) FDA News Release 8 June 2006. 2006, (accessed 24 Jan 2007)., http://www.fda.gov/bbs/topics/NEWS/2006/NEW01385.html
11. Hanisch R, Gustat J, Hagensee ME, Baena A, Salazar JE, Castro MV, Gaviria AM, Sánchez GI. Knowledge of Pap screening and human papillomavirus among women attending clinics in Medellín, Colombia. Int J Gynecol Cancer 2008, 18:1020-6. 10.1111/j.1525-1438.2007.01131.x, 18021221.
12. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J. Awareness of human papillomavirus among women attending a well woman clinic. Sex Transm Infect 2003, 79:320-2. 10.1136/sti.79.4.320, 1744711, 12902585.
13. Nøhr B, Munk C, Tryggvadottir L, Sparén P, Tran TN, Nygård M, Skare GB, Dasbach E, Liaw KL, Kjaer SK. Awareness of human papillomavirus in a cohort of nearly 70,000 women from four Nordic countries. Acta Obstet Gynecol Scand 2008, 87:1048-54.
14. Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the U.S. know about human papillomavirus and cervical cancer?. Cancer Epidemiol Biomarkers Prev 2007, 16:288-94. 10.1158/1055-9965.EPI-06-0756, 17267388.
15. Marlow LA, Waller J, Wardle J. Public awareness that HPV is a risk factor for cervical cancer. Br J Cancer 2007, 97:691-4. 10.1038/sj.bjc.6603927, 2360359, 17687335.
16. Di Giuseppe G, Abbate R, Liguori G, Albano L, Angelillo IF. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br J Cancer 2008, 99:225-9. 10.1038/sj.bjc.6604454, 2480983, 18628763.
17. Moreira ED, Oliveira BG, Ferraz FM, Costa S, Costa Filho JO, Karic G. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention. Int J Gynecol Cancer 2006, 16:599-603. 10.1111/j.1525-1438.2006.00377.x, 16681732.
18. Sauvageau C, Duval B, Gilca V, Lavoie F, Ouakki M. Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada. BMC Public Health 2007, 7:304. 10.1186/1471-2458-7-304, 2206027, 17961209.
19. Kwan TT, Chan KK, Yip AM, Tam KF, Cheung AN, Lo SS, Lee PW, Ngan HY. Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications. BJOG 2009, 116:501-10. 10.1111/j.1471-0528.2008.01988.x, 19250361.
20. Lazcano-Ponce E, Rivera L, Arillo-Santillán E, Salmerón J, Hernández-Avila M, Muñoz N. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 2001, 32:243-7. 10.1016/S0188-4409(01)00277-6, 11395192.
21. Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004, 8:188-94. 10.1097/00128360-200407000-00005, 15874862.
22. Baykal C, Al A, Uǧur MG, Cetinkaya N, Attar R, Arioglu P. Knowledge and interest of Turkish women about cervical cancer and HPV vaccine. Eur J Gynaecol Oncol 2008, 29:76-9.
23. Brasil. Ministério da Saúde. Portaria N° 3.124 de 7 de dezembro de 2006 Vacina quadrivalente recombinante contra papilomavírus humanos. 2006, Diário Oficial da União; Poder Executivo, de 28 de agosto de, (accessed 20 Dec 2010), Brasil. Ministério da Saúde. Portaria N° 3.124 de 7 de dezembro de 2006., ftp://ftp.saude.sp.gov.br/ftpsessp/bibliote/informe_eletronico/2006/iels.dezembro.06/iels236/U_PT-MS-GM-3124_071206.pdf
24. Brasil. Ministério da Saúde. Resolução -RE No- 474, DE 21 de fevereiro de 2008 Vacina contra HPV oncogênico (16 e 18, recombinante, com advuvante AS04). 2008, Diário Oficial da União; Poder Executivo, de 25 de fevereiro de, (accessed 02 October 2010), Brasil. Ministério da Saúde. Resolução -RE No- 474, DE 21 de fevereiro de 2008., http://www.anvisa.gov.br/legis/suplemento/250208_suplemento_1.pdf
25. Brasil. Instituto Nacional de Câncer [INCA]. Coordenação de Prevenção e Vigilância Estimativa 2008: Incidência de Câncer no Brasil. 2008, Rio de Janeiro, (accessed 20 Dec 2010), Brasil. Instituto Nacional de Câncer [INCA]. Coordenação de Prevenção e Vigilância., http://www.inca.gov.br/conteudo_view.asp?id=1793